Does Dupuytren’s disease affect life expectancy?

Dupuytren's disease is a common condition that causes lumps and thickened tissue in the palms of the hands. Over time, it can cause one or more fingers to bend towards the palm.
Dr Richard Shaffer, Consultant Clinical Oncologist and medical reviewer

Medically reviewed by: Dr Richard Shaffer

Consultant Clinical Oncologist

Dupuytren’s is related to other conditions involving abnormal tissue growth, including Ledderhose disease, which affects the feet, and Peyronie’s disease, which affects the penis. Researchers have investigated whether people with Dupuytren’s are more likely to develop serious illnesses, including heart disease, stroke and cancer, and whether having the condition is associated with a change in life expectancy.

 

Some studies have found an increased risk of death from several causes over the longer term, but others have found that people with Dupuytren’s have a lower risk of death during the earlier years following diagnosis. 

 

So what does the research tell us, and what does it mean if you have Dupuytren’s disease?

What have studies found about life expectancy?

If you’ve read about a possible link between Dupuytren’s and reduced life expectancy, it’s understandable that you might be concerned. These findings describe patterns across large groups of people and cannot predict how long any individual person will live for. There are also practical steps you can take to improve your long-term health.

 

Two important studies have investigated this question. A large UK study published in 2020 found that people with Dupuytren’s had a lower risk of death during the first 12 years after diagnosis, followed by a higher risk in later years. A Dutch study published in 2024 also found a lower risk of death, although it followed patients for a shorter period.

What did the UK study find?

In 2020, researchers at the University of Oxford published a study comparing nearly 42,000 people with Dupuytren’s disease with 210,000 people without it. They used medical records and information about causes of death to investigate whether people with Dupuytren’s were more likely to die over time, and which health conditions might be responsible. 

 

They found two distinct patterns:

  • During the first 12 years after diagnosis, people with Dupuytren’s had a 20% lower relative rate of death than those without the condition.
  • After 12 years, people with Dupuytren’s had a 43% higher relative rate of death, after accounting for several other health factors.

 

The researchers also found an increased risk of death from cardiovascular disease (including heart disease and stroke), cancer and respiratory disease during the later period.

What does the 43% increase mean?

The 43% figure is a relative increase in the rate of death, rather than an absolute increase of 43 percentage points. These are very different things.

 

For example, imagine that 10 out of every 100 people in one group died during a particular period. A 43% relative increase would mean about 14 out of every 100 people dying in the other group.

 

In this example, the relative increase is 43%, but the absolute increase is only about 4 percentage points, from 10% to 14%. An absolute increase of 43 percentage points would mean the risk rising from 10% to 53%, which is much larger.

 

These figures are illustrative rather than actual results from the study. The researchers measured the relative rate of death over time, which is slightly different from comparing the percentage of people who died over a fixed period.

 

The study therefore provides evidence of an increased long-term risk, but it cannot tell us how much an individual person’s life expectancy might be affected.

When does the 12-year period begin?

The researchers measured time from when Dupuytren’s disease was first recorded during a GP consultation. This matters because Dupuytren’s can develop gradually, and someone may have had nodules or cords for many years before seeking medical advice.

 

The study therefore doesn’t establish that the risk changes at 12 years after the disease first develops. It also doesn’t tell us anything specific about whether people with early nodules have the same long-term risks as those with more advanced finger contractures.

What did the Dutch study find?

A Dutch study published in 2024 compared 2,561 people with Dupuytren’s disease with people of similar backgrounds who did not have the condition. The researchers followed patients for a median of just over five years and found that people with Dupuytren’s had a lower overall risk of death. 

 

They also examined deaths from heart disease, stroke and cancer, but did not find clear evidence of a difference for each cause individually.

Do the UK and Dutch studies contradict each other?

At first glance, the findings seem different. The UK study reported an increased risk of death in people with Dupuytren’s, whereas the Dutch study found a reduced risk.

 

However, the UK study actually found a lower risk of death during the first 12 years after diagnosis. The increased risk only appeared in the later years, beyond the five-year period covered by the Dutch study. Both studies therefore found a lower risk of death during the earlier years after diagnosis. The Dutch study was not long enough to establish whether that pattern would eventually change.

 

The findings don’t prove that everyone with Dupuytren’s experiences the same pattern, but they suggest that the length of time people were followed in the studies may explain the different results.

What does this research mean for you?

The UK study found that the increased risk of death only became apparent many years after diagnosis. This gives people with Dupuytren’s an opportunity to improve their long-term health by addressing factors such as smoking, drinking too much alcohol, and diabetes, all of which can increase the risk of heart disease, stroke and cancer.

 

There are several practical steps you can take:

 

If you are concerned about your general health or heart disease risk, your GP can help you decide whether any assessment is needed. Having Dupuytren’s disease alone does not mean that you automatically need additional medical tests.

Why might Dupuytren's be linked to a higher risk of death?

There are several possible explanations, and more than one may be involved:

Shared risk factors

Smoking, diabetes and higher alcohol consumption are all associated with an increased likelihood of developing Dupuytren’s disease. These factors also increase the risk of serious health problems such as heart disease, stroke, cancer and liver disease.

 

This means that someone might be more likely to develop both Dupuytren’s and another serious condition because of factors they have in common.

 

The UK researchers tried to account for this by comparing people with similar smoking histories, diabetes status and body weight. This is called adjusting for risk factors, and it helps separate the association with Dupuytren’s from the effects of these other health risks. Taking these factors into account explained some of the increased risk of death, but people with Dupuytren’s still had a higher risk after 12 years. Alcohol use could not be included in this adjustment because it was recorded too inconsistently in medical records.

 

Common genetic or biological causes

Another possibility is that Dupuytren’s and some other diseases share underlying causes that affect how cells grow.

 

Dupuytren’s involves abnormal growth of cells that form the thickened tissue and cords in the hand. Cancer also involves abnormal cell growth, although the two conditions are very different.

 

Researchers have found that some of the same genes that control cell growth are involved in both Dupuytren’s and cancer. This raises the possibility that shared genetic factors might help explain the increased risk of death from cancer found in the UK study, although further research is needed to understand this connection.

FAQs

Could Dupuytren's itself affect life expectancy?

Dupuytren’s can cause substantial problems with hand function, particularly when finger contractures become severe. However, there is no convincing evidence that the changes in the hands themselves directly cause the increased risk of death found in these studies.

The evidence is mixed, and we don’t yet know whether people with Dupuytren’s are more likely to develop cancer.

 

The UK study found an increased risk of death from cancer more than 12 years after a Dupuytren’s diagnosis. However, the Dutch study did not find an increased risk of cancer-related death during its five-year follow-up.

The research suggests that people with Dupuytren’s may have an increased risk of death in the longer term, but this doesn’t mean that your life will be shorter. You can take steps to address some of the factors that may contribute to this risk, such as stopping smoking, drinking less and managing your diabetes well. This could make a real difference to your long-term health and life expectancy.

You may also have questions about Dupuytren’s disease itself, including whether it will progress and when treatment might be appropriate. Our guide to treatments for Dupuytren’s disease explains the different treatment options, when they may be suitable and what you can expect from them.

 

If you are considering radiotherapy for early-stage Dupuytren’s, you can read about radiotherapy treatment for Dupuytren’s disease in the UK, or arrange a consultation to discuss your own hands with our team.

Expert-Led Radiotherapy for Dupuytren’s and Ledderhose Disease

Every case of Dupuytren’s or Ledderhose disease is different. Dr Richard Shaffer can assess your condition and help you understand whether radiotherapy may be suitable. Take the next step towards an informed treatment decision.

Related Posts

Get a call from Dr Shaffer’s team

Concerned about Dupuytren's Contracture or Ledderhose Disease? Book your free call to discuss how we can help.